Leukemias: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for adults with leukemia. To learn more about a study, choose from the list below.

For clinical trials for children with leukemia, please visit Pediatric Clinical Trials.

You can also visit our Blood & Marrow Stem Cell Transplantation Clinical Trials.

Showing 20 trials
Titlesort icon Investigator
A Phase I Study of Consolidation Therapy with Autologous T Cells Genetically Targeted to CD19 in Patients with Chronic Lymphocytic Leukemia After Initial Chemotherapy
[Protocol 11-048] 		Park, Jae, MD
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
[Protocol 06-138] 		Brentjens, Renier, MD, PhD
A Phase I Study of Induction Therapy with Cytarabine, High-Dose Mitoxantrone, and Dasatinib for Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
[Protocol 09-046] 		Lamanna, Nicole, MD
A Phase I Trial of B-Cell Acute Lymphoblastic Leukemia Treated with Autologous T Cells Gene-Targeted to the B-Cell Antigen CD19
[Protocol 09-114] 		Brentjens, Renier, MD, PhD
A Phase I-II Study of Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Previously Treated Patients with Chronic Lymphocytic Leukemia and Other Low Grade B-Cell Cancers
[Protocol 05-077] 		Lamanna, Nicole, MD
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
[Protocol 05-103] 		Gerecitano, John, MD, PhD
A Phase I/II Study of Decitabine and All-Trans Retinoic Acid (Tretinoin) for Patients with Myelodysplastic Syndromes
[Protocol 06-054] 		Klimek, Virginia, MD
A Phase II Study of CAL-101 plus Rituximab in Elderly Patients with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
[Protocol 10-224] 		Lamanna, Nicole, MD
A Phase II Study of Lenalidomide in Patients with Chronic Lymphocytic Leukemia Age 65 and Older
[Protocol 09-045] 		Lamanna, Nicole, MD
A Phase II Study of Maitake Mushroom Extract in Patients with Low-Risk, Untreated Myelodysplastic Syndrome
[Protocol 09-094] 		Wesa, Kathleen, MD
A Phase II Study of Midostaurin in Patients with Aggressive Systemic Mastocytosis or Mast Cell Leukemia
[Protocol 10-006] 		Heaney, Mark, MD, PhD
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040] 		Jurcic, Joseph, MD
A Phase III Study of Cytarabine with or without Vosaroxin in Patients with First Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 11-094] 		Rosenblat, Todd, MD
A Phase III Study of Elacytarabine versus Investigator's Choice in Patients with Late-Stage Acute Myeloid Leukemia
[Protocol 10-113] 		Rosenblat, Todd, MD
A Phase III Study of Lenalidomide Alone and in Combination with Epoetin Alfa in Patients with Myelodysplastic Syndromes and Symptomatic Anemia
[Protocol 10-128] 		Klimek, Virginia, MD
A Phase III Study of Pomalidomide versus Placebo in Patients with Myeloproliferative Neoplasm-Associated Myelofibrosis Who Are Dependent on Red Blood Cell Transfusions
[Protocol 11-025] 		Heaney, Mark, MD, PhD
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia
[Protocol 08-087] 		Barker, Juliet, MBBS
A Study of Posaconazole Versus Micafungin to Protect Against Invasive Fungal Infections in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
[Protocol 10-038] 		Papanicolaou, Genovefa, MD
Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High-Risk Chronic Lymphocytic Leukemia
[Protocol 11-024] 		Perales, Miguel-Angel, MD
Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143] 		Maslak, Peter, MD
Recommended Links

Clinical Trials

Clinical trials can offer you access to a new, experimental treatment before it is available to most patients. Joining a clinical trial is also a way to make a valuable contribution toward the fight against cancer.